Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogressive Lung Non-Small Cell Carcinoma”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Looking for participantsNCT07193641
What this trial is testing

A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Large-scale testing (Phase 3)Looking for participantsNCT06686771
What this trial is testing

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Canadian Cancer Trials Group 320
Not applicableLooking for participantsNCT06103682
What this trial is testing

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Who this might be right for
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
University of California, Davis 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089916
What this trial is testing

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Who this might be right for
NSCLCEGFR Positive Non-small Cell Lung CancerOligoprogression
AIO-Studien-gGmbH 42
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781202
What this trial is testing

A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined With Radiotherapy in Patients With HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer

Who this might be right for
HER2-mutated Advanced Non-small Cell Lung Cancer With Oligoprogression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Ended earlyNCT04549428
What this trial is testing

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

Who this might be right for
NSCLC Stage IV
Oncology Institute of Southern Switzerland 12
Testing effectiveness (Phase 2)WithdrawnNCT04485026
What this trial is testing

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Who this might be right for
Non Small Cell Lung CancerOligoprogressive
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)UnknownNCT04970693
What this trial is testing

Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Who this might be right for
Non-small Cell Lung CancerOligoprogressive
Sun Yat-sen University 64
Not applicableUnknownNCT04216121
What this trial is testing

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven 39
Testing effectiveness (Phase 2)Study completedNCT02759835
What this trial is testing

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

Who this might be right for
Lung AdenocarcinomaLung Neoplasms
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT05830058
What this trial is testing

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Who this might be right for
Lung Non-Small Cell CarcinomaMalignant Solid NeoplasmMelanoma+1 more
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT04892953
What this trial is testing

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Who this might be right for
Stage III Lung Cancer AJCC v8Stage III Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Temporarily pausedNCT06014827
What this trial is testing

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
City of Hope Medical Center 32
Testing effectiveness (Phase 2)UnknownNCT05387044
What this trial is testing

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Zhejiang Cancer Hospital 28
Next Page